Breaking news

Apple Ordered To Remit $634 Million For Patent Infringement

Apple Inc. now faces a staggering $634 million judgment after a California federal jury found the tech giant infringed on Masimo’s patent regarding blood oxygen monitoring technology.

Landmark Intellectual Property Ruling

The verdict, reported by Reuters, centers on the Apple Watch’s workout and heart rate notification features, which the jury determined unlawfully incorporated Masimo’s patented pulse oximetry innovations. According to Masimo, a leader in medical device technology (Masimo), this legal win is a critical measure to safeguard their technological advancements that directly benefit patient care.

Strategic Implications For Apple

An Apple spokesperson noted plans to appeal the decision, contesting that the patent in question expired in 2022 and dated back to outdated patient monitoring methods. This response underscores a broader debate over legacy technologies versus evolving innovation paradigms.

Broader Context Of The Dispute

The contentious legal battle extends beyond patent infringement alone. Masimo has previously accused Apple of recruiting its talent, including the company’s chief medical officer, to leverage its pulse oximetry expertise. The United States International Trade Commission further bolstered Masimo’s stance in 2023 by banning Apple from importing devices featuring blood oxygen monitoring capabilities—a cautionary precedent that has prompted Apple to re-engineer the function to operate on the paired iPhone rather than the watch.

Counterlitigation And Ongoing Legal Challenges

As the litigation landscape evolves, Masimo is also challenging U.S. Customs and Border Patrol for approving the new Apple Watch imports, while Apple has escalated its contest to higher courts, seeking reversal of the import ban. In a related development, Apple secured a $250 statutory minimum in a countersuit after a jury found Masimo had infringed on its design patents.

This case not only highlights the high stakes involved in protecting intellectual property but also reflects the broader tensions at the intersection of innovation, talent acquisition, and competitive market dynamics in the technology sector.

SEC Drops Lawsuit Against Gemini: A Major Turning Point In Crypto Regulation

SEC Dismisses Legal Action Against Gemini

The Securities and Exchange Commission has formally withdrawn its lawsuit against Gemini, the prominent crypto exchange founded by twins Cameron and Tyler Winklevoss. The move follows a joint court filing in which both the regulator and Gemini sought dismissal of the case that centered on the collapse of the Gemini Earn investment product, a debacle that left investors without access to their funds for 18 months.

Settlement And Regulatory Reassessment

In a significant development, a 2024 settlement between New York and Gemini ensured that investors recovered one hundred percent of their crypto assets loaned through the Gemini Earn program. The legal reprieve comes on the heels of actions initiated by New York Attorney General Letitia James, who accused Gemini of defrauding investors.

Political Backdrop And Industry Implications

This dismissal reinforces a broader trend of regulatory leniency toward the crypto sector noted during the Trump administration, which saw the SEC dismiss, pause, or reduce penalties in more than 60 percent of its pending crypto lawsuits. Meanwhile, Gemini’s recent public offering filing underscores its ambitions to solidify its status as a major player in the evolving digital asset market.

The Future Forbes Realty Global Properties
Uol
eCredo
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter